Philip Morris International (PM) in Focus on Dec. 25, 2025: Dividend Deadline, ZYN FDA Catalyst, and 2026 Stock Forecasts
December 25, 2025 — With U.S. markets closed for the Christmas holiday, investor attention has shifted from intraday price moves to the next set of catalysts for Philip Morris International Inc. (NYSE: PM): a dividend deadline arriving tomorrow, an increasingly consequential FDA process around ZYN nicotine pouches, and a growing tug-of-war between “sin stock” discounts and a rapidly expanding smoke-free business. A cluster of fresh Christmas Day analyses frames the debate in unusually clear terms. One argues PM is still undervalued even after a strong year, another highlights the market’s persistent ethical discount for tobacco, while several forecast roundups show